IONS Oct 2024 35.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:54PM EDT. Market open.
| Previous close | 10.70 |
| Open | N/A |
| Bid | 8.50 |
| Ask | 9.10 |
| Strike | 35.00 |
| Expiry date | 2024-10-18 |
| Day's range | 10.70 - 10.70 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
ZacksIonis Pharmaceuticals (IONS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Ionis Pharmaceuticals (IONS) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
ZacksIonis Pharmaceuticals (IONS) Reports Q1 Loss, Misses Revenue Estimates
Ionis Pharmaceuticals (IONS) delivered earnings and revenue surprises of 10.91% and 9.51%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
PR NewswireIonis reports first quarter 2024 financial results
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) (the "Company"), today reported financial results for the first quarter ended March 31, 2024.
© 2024 Yahoo. All rights reserved.